PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

In the category of no good deed goes unpunished...



The New York Times published a piece on December 9, "Cholesterol-Fighting Drugs Show Wider Benefit" reporting on a study that showed that cholesterol-lowering drugs, statins, can significantly lower the risk of heart attacks, stroke and death, even in people with low cholesterol levels:


"The study, presented Sunday at an American Heart Associationconvention in New Orleans and published online in The New England Journal of Medicine, found that the risk of heart attack was more than cut in half for people who took statins."


The study was paid for by AstraZeneca, which makes the drug tested, rosuvastatin, sold as Crestor. The TV networks absolutely loved this story, as you can see from the CBS News video and NBC Nightly News

So we did an online search: Crestor and "Class-Action" Lawsuit.

Related Entries:

 

 


Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute
igorodetski@manhattan-institute.org

Katherine Lazarski
Press Officer,
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.